Medical Device Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Class I, Class II, Class III), By Services (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing, Device Manufacturing, Packaging & Labeling, Others), By Therapeutic Area (Cardiovascular Devices, Orthopedic Devices, Ophthalmic Devices, Diagnostic Devices, Respiratory Devices, Surgical Instruments, Dental, Others), By End Use (Original Equipment Manufacturers (OEMs), Pharmaceutical & Biopharmaceutical Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034
What is the Size of Medical Device Contract Manufacturing Market?
The medical device contract manufacturing market size was valued at USD 85.93 billion in 2025 and is projected to grow from USD 96.22 billion in 2026 to USD 243.88 billion by 2034 at a CAGR of 12.33% during the forecast period (2026-2034), as per Straits Research Analysis.
Key Market Insights
- North America dominated the medical device contract manufacturing market with the largest share of 50.27% in 2025.
- The Asia Pacific is expected to be the fastest-growing region in the medical device contract manufacturing market during the forecast period at a CAGR of 14.33%.
- Based on product, the Class III segment is expected to register a CAGR of 13.23% during the forecast period.
- Based on services, the accessories manufacturing segment dominated the market with 51.24% share in 2025.
- Based on therapeutic area, the cardiovascular devices segment dominated the market with a share of 28.14% in 2025.
- Based on end use, the pharmaceutical & biopharmaceutical companies segment is expected to register a CAGR of 13.23% during the forecast period.
- The US medical device contract manufacturing market size was valued at USD 38.93 billion in 2025 and is projected to reach USD 43.59 billion in 2026.
Market Summary
| Market Metric | Details & Data (2025-2034) |
|---|---|
| 2025 Market Valuation | USD 85.93 billion |
| Estimated 2026 Value | USD 96.22 billion |
| Projected 2034 Value | USD 243.88 billion |
| CAGR (2026-2034) | 12.33% |
| Dominant Region | North America |
| Fastest Growing Region | Asia Pacific |
| Key Market Players | Halozyme b, MediLink Therapeutics, ImmunityBio, Jabil Inc., Thermo Fisher Scientific Inc. |
to learn more about this report Download Free Sample Report
What are the Latest Trends in Medical Device Contract Manufacturing Market?
Rising demand for innovative medical devices drives a transition toward outsourcing production to specialized contract manufacturers. Device companies increasingly collaborate with CDMOs to leverage advanced manufacturing capabilities, reduce capital expenditures, and accelerate time-to-market for new products. This trend strengthens the role of contract manufacturers in scaling production, maintaining quality standards, and supporting faster commercialization of innovative medical technologies.
Adoption of advanced manufacturing technologies, including automation and additive manufacturing, drives a transition toward more precise and efficient contract manufacturing processes. Manufacturers integrate robotics, 3D printing, and digital quality monitoring to improve production accuracy, reduce errors, and optimize workflow efficiency. This shift enhances product consistency, shortens production timelines, and allows contract manufacturers to meet increasingly complex device specifications.
What are the Key Drivers in Medical Device Contract Manufacturing Market?
Rising demand for minimally invasive and wearable medical devices increases the need for specialized contract manufacturing services. Medical device companies rely on CDMOs to produce complex components such as sensors, catheters, and implantable devices with high precision. This drives growth in contract manufacturing as manufacturers expand capacity and adopt advanced production techniques to meet evolving device requirements.
Global expansion of healthcare infrastructure and hospital networks boosts demand for standardized medical devices. Device companies partner with contract manufacturers to efficiently produce large volumes of consumables, diagnostic tools, and therapeutic equipment for new and existing healthcare facilities. This results in increased outsourcing of production, enabling faster supply chain responsiveness and meeting regional healthcare demands.
Which Factors are Limiting the Growth of Medical Device Contract Manufacturing Market?
Strict regulatory requirements limit the ability of medical device companies to quickly switch to contract manufacturers. Manufacturers must ensure that CDMOs comply with FDA, ISO, and EU MDR standards, which require extensive audits and quality validation. This slows the adoption of outsourcing and increases operational costs, particularly for smaller device companies with limited compliance resources.
Significant upfront investment in specialized manufacturing capabilities restricts the number of qualified contract manufacturers. Advanced devices often require precision tooling, cleanroom facilities, and high-tech assembly lines, which demand substantial capital and operational expertise. This barrier reduces the availability of capable partners and slows market expansion for complex medical device contract manufacturing.
What are the Growth Opportunities for Players in Medical Device Contract Manufacturing Market?
Integration of digital manufacturing, IoT, and smart quality control opens opportunities for contract manufacturers to differentiate their services. Advanced monitoring, predictive maintenance, and automated production systems improve efficiency, product consistency, and regulatory compliance. This transition enables CDMOs to offer higher-value services and attract clients seeking innovative, reliable, and technology-driven device production solutions.
Increasing emphasis on sustainability and eco-friendly production opens opportunities for contract manufacturers to adopt green manufacturing practices. By implementing energy-efficient processes, recyclable materials, and waste reduction systems, manufacturers can meet regulatory and customer expectations for sustainable device production. This allows CDMOs to differentiate themselves, attract environmentally conscious clients, and strengthen long-term partnerships with device companies.
Regional Analysis
North America Medical Device Contract Manufacturing Market
The North American market had a share of 50.27% in 2025. The market is growing due to strong innovation pipelines from universities, research hospitals, and federal research programs. The US National Institutes of Health (NIH) funds large volumes of biomedical engineering and medical technology research each year, creating a steady flow of prototype devices that require specialized external manufacturing for scaling and commercialization. The US also has a large network of small- and mid-size medical device innovators that often lack in-house manufacturing infrastructure and rely on contract manufacturers for precision machining, electronics integration, and sterile packaging. Many manufacturers outsource production to facilities that comply with US FDA Quality System Regulation (21 CFR Part 820) to ensure regulatory compliance and faster product approvals. The expansion of advanced technologies such as robotic surgery systems and connected diagnostic devices in US hospitals is increasing demand for contract manufacturers capable of producing high-precision electronic components and miniaturized device assemblies.
Asia Pacific Medical Device Contract Manufacturing Market
The medical device contract manufacturing market in the Asia Pacific is expected to register a CAGR of 14.33% during the forecast period. The market is growing due to rapid growth of electronics and semiconductor manufacturing capabilities that support modern medical technologies. Countries such as Japan, South Korea, and Taiwan possess strong expertise in microelectronics, sensors, and precision component manufacturing, which are critical for wearable medical devices, imaging equipment, and diagnostic systems. Governments in the region are also developing specialized medical device industrial parks to support domestic production. For example, India has established dedicated medical device parks under government initiatives to improve infrastructure for device manufacturing and testing. The region’s strong supply chains for plastics, electronics, and metal fabrication allow contract manufacturers to produce complex device components efficiently. The rising adoption of digital health technologies and portable monitoring devices across Asia Pacific healthcare systems is also increasing demand for electronics-focused contract manufacturing services.
Europe Medical Device Contract Manufacturing Market
The market in Europe is strongly influenced by strong innovation pipelines from universities, research hospitals, and federal research programs. The US National Institutes of Health (NIH) funds large volumes of biomedical engineering and medical technology research each year, creating a steady flow of prototype devices that require specialized external manufacturing for scaling and commercialization. The US also has a large network of small- and mid-size medical device innovators that often lack in-house manufacturing infrastructure and rely on contract manufacturers for precision machining, electronics integration, and sterile packaging. Many manufacturers outsource production to facilities that comply with US FDA Quality System Regulation (21 CFR Part 820) to ensure regulatory compliance and faster product approvals. The expansion of advanced technologies such as robotic surgery systems and connected diagnostic devices in US hospitals is increasing demand for contract manufacturers capable of producing high-precision electronic components and miniaturized device assemblies.
Middle East & Africa Medical Device Contract Manufacturing Market
The medical device contract manufacturing market in the Middle East & Africa is developing as governments increase investments in healthcare infrastructure and aim to strengthen regional medical technology capabilities. Many countries in the region are implementing national healthcare modernization programs that increase demand for diagnostic equipment, monitoring devices, and hospital technologies. Governments are also encouraging local production of medical equipment to reduce dependence on imports and strengthen supply chain resilience. The expansion of hospital networks, medical cities, and specialized healthcare facilities across countries such as Saudi Arabia and the United Arab Emirates creates opportunities for partnerships with international contract manufacturers. The growing adoption of advanced healthcare technologies and the gradual development of regulatory frameworks are supporting the emergence of regional medical device manufacturing activities.
Latin America Medical Device Contract Manufacturing Market
Latin America is witnessing gradual growth in medical device contract manufacturing driven by expanding healthcare demand and increasing manufacturing activities in countries such as Brazil and Mexico. Mexico has developed into an important medical device manufacturing hub due to its proximity to the US market and strong export-oriented manufacturing ecosystem. The presence of industrial clusters and trade agreements with North American markets encourages international device manufacturers to establish production partnerships with contract manufacturers in the region. Brazil also represents a major healthcare market in Latin America, with increasing government investments in healthcare services and medical technology procurement. The expansion of regional healthcare systems and growing demand for cost-effective medical technologies are encouraging outsourcing of device production to local manufacturing partners across the region.
Product Insights
Class II devices dominated the medical device contract manufacturing market with a share of 83.45% in 2025 due to their broad use in diagnostic, monitoring, and therapeutic applications such as infusion pumps, imaging equipment, and surgical tools. These devices require controlled manufacturing processes and regulatory compliance, which encourages OEMs to outsource production to specialized contract manufacturers. The consistent demand for mid-complexity medical technologies supports segment growth.
The Class III devices segment is expected to grow at a CAGR of 13.23% during the forecast period, as demand increases for advanced implantable and life-supporting technologies such as cardiac implants and neurostimulation devices. These products require highly specialized manufacturing, precision engineering, and strict regulatory compliance. Many companies rely on experienced contract manufacturers with advanced capabilities to scale production, supporting rapid growth in this segment.
Services Insights
Accessories manufacturing dominated the services segment with a share of 51.24% in 2025, as a wide range of medical devices require compatible components such as connectors, tubing, sensors, and disposable accessories. Contract manufacturers play a key role in producing these high-volume components with consistent quality and cost efficiency. The recurring demand for accessories used with diagnostic and therapeutic devices sustains the segment’s leading market share.
The device manufacturing segment is expected to grow at a CAGR of 13.56% during the forecast period, as more medical device companies outsource full device production rather than only components. Contract manufacturers now provide integrated services including engineering, production, testing, and quality assurance. The need for scalable manufacturing capacity for complex medical technologies is accelerating the growth of outsourced device manufacturing services.
Therapeutic Area Insights
Cardiovascular devices dominated the therapeutic area segment with a share of 28.14% in 2025 due to the high global prevalence of heart diseases and the widespread use of devices such as stents, pacemakers, and monitoring systems. These products require precision manufacturing and strict regulatory compliance. Many manufacturers partner with contract manufacturers to ensure quality production and efficient scaling of cardiovascular device manufacturing.
The ophthalmic devices segment is expected to grow at a CAGR of 13.13%, driven by rising demand for vision correction technologies, diagnostic equipment, and minimally invasive eye surgery devices. The increasing number of cataract and retinal procedures has accelerated production needs. Contract manufacturers with micro-precision manufacturing capabilities support the rapid expansion of ophthalmic device production.
End Use Insights
Original equipment manufacturers dominated the end-use segment with a share of 54.23% in 2025, as many medical device companies outsource manufacturing to focus on research, product development, and commercialization. Contract manufacturers provide specialized production infrastructure, regulatory expertise, and scalable capacity. This allows OEMs to reduce operational costs while maintaining product quality and accelerating device market entry.
The pharmaceutical & biopharmaceutical companies segment is expected to grow at a CAGR of 13.23% during the forecast period due to the increasing development of drug-device combination products such as auto-injectors, inhalers, and wearable delivery systems. These products require integration of pharmaceutical formulation with device engineering. Contract manufacturers offer specialized production capabilities that support the expanding demand for combination therapy devices.
Competitive Landscape
The medical device contract manufacturing market is highly fragmented, comprising a mix of established multinational corporations, regional players, and innovative niche companies. Established players primarily compete on factors such as brand reputation, large-scale manufacturing capabilities, distribution networks, and regulatory compliance, leveraging their experience and resources to maintain market share. Emerging players, on the other hand, focus on innovation, specialized product offerings, cost-effectiveness, and agility to quickly address evolving customer needs. In the future, the market will be shaped by technological advancements, regulatory shifts, and the ability of players to deliver differentiated, sustainable, and patient-centric solutions.
List of Key and Emerging Players in Medical Device Contract Manufacturing Market
- Halozyme b
- MediLink Therapeutics
- ImmunityBio
- Jabil Inc.
- Thermo Fisher Scientific Inc.
- Integer Holdings Corporation
- FLEX LTD.
- Sanmina Corporation
- Celestica Inc.
- Phillips-Medisize
- Plexus Corp.
- Nipro Corporation
- Viant Technology LLC
- West Pharmaceutical Services, Inc.
- Mack Molding
- Cirtec Medical
- Cogmedix
- Synecco Ltd
- TE Connectivity
- Keller Technology Corp.
- HDA Technology, Inc.
Latest News on Key and Emerging Players
| TIMELINE | COMPANY | DEVELOPMENT |
|---|---|---|
|
February 2026 |
ImmunityBio |
ImmunityBio engaged with the Saudi Food and Drug Authority under the USASaudi Biotech Alliance to expand indications for its immunotherapy ANKTIVA and advance rBCG submissions and established a whollyowned subsidiary in Saudi Arabia for regional operations. |
|
January 2026 |
MediLink Therapeutics |
MediLink Therapeutics signed an exclusive global licensing and collaboration agreement with Roche in January 2026 for its antibodydrug conjugate YL201 targeting solid tumors. |
|
December 2025 |
Halozyme |
Halozyme entered a non-exclusive global collaboration with Skye Bioscience for access to ENHANZE technology to develop and potentially commercialize a subcutaneous (SC) formulation of nimacimab for obesity. |
|
December 2025 |
Halozyme b |
Halozyme signed a global collaboration and exclusive license with Takeda leveraging ENHANZE for use with vedolizumab (ENTYVIO) in Crohn’s disease and ulcerative colitis. |
Source: Secondary Research
Report Scope
| Report Metric | Details |
|---|---|
| Market Size in 2025 | USD 85.93 billion |
| Market Size in 2026 | USD 96.22 billion |
| Market Size in 2034 | USD 243.88 billion |
| CAGR | 12.33% (2026-2034) |
| Base Year for Estimation | 2025 |
| Historical Data | 2022-2024 |
| Forecast Period | 2026-2034 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
| Segments Covered | By Product, By Services, By Therapeutic Area, By End Use |
| Geographies Covered | North America, Europe, APAC, Middle East and Africa, LATAM |
| Countries Covered | US, Canada, UK, Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Singapore, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia |
to learn more about this report Download Free Sample Report
Medical Device Contract Manufacturing Market Segments
By Product
- Class I
- Class II
- Class III
By Services
- Accessories Manufacturing
- Assembly Manufacturing
- Component Manufacturing
- Device Manufacturing
- Packaging & Labeling
- Others
By Therapeutic Area
- Cardiovascular Devices
- Orthopedic Devices
- Ophthalmic Devices
- Diagnostic Devices
- Respiratory Devices
- Surgical Instruments
- Dental
- Others
By End Use
- Original Equipment Manufacturers (OEMs)
- Pharmaceutical & Biopharmaceutical Companies
- Others
By Region
- North America
- Europe
- APAC
- Middle East and Africa
- LATAM
Frequently Asked Questions (FAQs)
Debashree Bora
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
